494 related articles for article (PubMed ID: 29272738)
1. Monomeric amyloid-β reduced amyloid-β oligomer-induced synapse damage in neuronal cultures.
Bate C; Williams A
Neurobiol Dis; 2018 Mar; 111():48-58. PubMed ID: 29272738
[TBL] [Abstract][Full Text] [Related]
2. Glimepiride protects neurons against amyloid-β-induced synapse damage.
Osborne C; West E; Nolan W; McHale-Owen H; Williams A; Bate C
Neuropharmacology; 2016 Feb; 101():225-36. PubMed ID: 26432105
[TBL] [Abstract][Full Text] [Related]
3. Sialylated glycosylphosphatidylinositols suppress the production of toxic amyloid-β oligomers.
Nolan W; McHale-Owen H; Bate C
Biochem J; 2017 Aug; 474(17):3045-3058. PubMed ID: 28729427
[TBL] [Abstract][Full Text] [Related]
4. Amyloid-β-induced synapse damage is mediated via cross-linkage of cellular prion proteins.
Bate C; Williams A
J Biol Chem; 2011 Nov; 286(44):37955-37963. PubMed ID: 21900234
[TBL] [Abstract][Full Text] [Related]
5. The cholesterol ester cycle regulates signalling complexes and synapse damage caused by amyloid-β.
West E; Osborne C; Bate C
J Cell Sci; 2017 Sep; 130(18):3050-3059. PubMed ID: 28760925
[TBL] [Abstract][Full Text] [Related]
6. Amyloid-β(1-40) inhibits amyloid-β(1-42) induced activation of cytoplasmic phospholipase A2 and synapse degeneration.
Bate C; Williams A
J Alzheimers Dis; 2010; 21(3):985-93. PubMed ID: 20634578
[TBL] [Abstract][Full Text] [Related]
7. An in vitro model for synaptic loss in neurodegenerative diseases suggests a neuroprotective role for valproic acid via inhibition of cPLA2 dependent signalling.
Williams RS; Bate C
Neuropharmacology; 2016 Feb; 101():566-75. PubMed ID: 26116815
[TBL] [Abstract][Full Text] [Related]
8. Cholesterol ester hydrolase inhibitors reduce the production of synaptotoxic amyloid-β oligomers.
McHale-Owen H; Bate C
Biochim Biophys Acta Mol Basis Dis; 2018 Mar; 1864(3):649-659. PubMed ID: 29247837
[TBL] [Abstract][Full Text] [Related]
9. Monoacylated Cellular Prion Proteins Reduce Amyloid-β-Induced Activation of Cytoplasmic Phospholipase A2 and Synapse Damage.
West E; Osborne C; Nolan W; Bate C
Biology (Basel); 2015 Jun; 4(2):367-82. PubMed ID: 26043272
[TBL] [Abstract][Full Text] [Related]
10. Taxifolin prevents β-amyloid-induced impairments of synaptic formation and deficits of memory via the inhibition of cytosolic phospholipase A
Wang Y; Wang Q; Bao X; Ding Y; Shentu J; Cui W; Chen X; Wei X; Xu S
Metab Brain Dis; 2018 Aug; 33(4):1069-1079. PubMed ID: 29542038
[TBL] [Abstract][Full Text] [Related]
11. Valproic acid and its congener propylisopropylacetic acid reduced the amount of soluble amyloid-β oligomers released from 7PA2 cells.
Williams RSB; Bate C
Neuropharmacology; 2018 Jan; 128():54-62. PubMed ID: 28947378
[TBL] [Abstract][Full Text] [Related]
12. Alzheimer amyloid-β oligomer bound to postsynaptic prion protein activates Fyn to impair neurons.
Um JW; Nygaard HB; Heiss JK; Kostylev MA; Stagi M; Vortmeyer A; Wisniewski T; Gunther EC; Strittmatter SM
Nat Neurosci; 2012 Sep; 15(9):1227-35. PubMed ID: 22820466
[TBL] [Abstract][Full Text] [Related]
13. Ethanol protects cultured neurons against amyloid-β and α-synuclein-induced synapse damage.
Bate C; Williams A
Neuropharmacology; 2011 Dec; 61(8):1406-12. PubMed ID: 21903110
[TBL] [Abstract][Full Text] [Related]
14. The phospholipase A
Osborne C; West E; Bate C
J Cell Sci; 2018 Apr; 131(8):. PubMed ID: 29588394
[TBL] [Abstract][Full Text] [Related]
15. Interaction of amyloid-β (Aβ) oligomers with neurexin 2α and neuroligin 1 mediates synapse damage and memory loss in mice.
Brito-Moreira J; Lourenco MV; Oliveira MM; Ribeiro FC; Ledo JH; Diniz LP; Vital JFS; Magdesian MH; Melo HM; Barros-Aragão F; de Souza JM; Alves-Leon SV; Gomes FCA; Clarke JR; Figueiredo CP; De Felice FG; Ferreira ST
J Biol Chem; 2017 May; 292(18):7327-7337. PubMed ID: 28283575
[TBL] [Abstract][Full Text] [Related]
16. Cellular prion protein as a therapeutic target in Alzheimer's disease.
Laurén J
J Alzheimers Dis; 2014; 38(2):227-44. PubMed ID: 23948943
[TBL] [Abstract][Full Text] [Related]
17. Alzheimer's therapeutics targeting amyloid beta 1-42 oligomers I: Abeta 42 oligomer binding to specific neuronal receptors is displaced by drug candidates that improve cognitive deficits.
Izzo NJ; Staniszewski A; To L; Fa M; Teich AF; Saeed F; Wostein H; Walko T; Vaswani A; Wardius M; Syed Z; Ravenscroft J; Mozzoni K; Silky C; Rehak C; Yurko R; Finn P; Look G; Rishton G; Safferstein H; Miller M; Johanson C; Stopa E; Windisch M; Hutter-Paier B; Shamloo M; Arancio O; LeVine H; Catalano SM
PLoS One; 2014; 9(11):e111898. PubMed ID: 25390368
[TBL] [Abstract][Full Text] [Related]
18. Breaking the Cycle, Cholesterol Cycling, and Synapse Damage in Response to Amyloid-β.
Bate C
J Exp Neurosci; 2017; 11():1179069517733096. PubMed ID: 29238218
[TBL] [Abstract][Full Text] [Related]
19. Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers.
Laurén J; Gimbel DA; Nygaard HB; Gilbert JW; Strittmatter SM
Nature; 2009 Feb; 457(7233):1128-32. PubMed ID: 19242475
[TBL] [Abstract][Full Text] [Related]
20. Dextran sulfate sodium inhibits amyloid-β oligomer binding to cellular prion protein.
Aimi T; Suzuki K; Hoshino T; Mizushima T
J Neurochem; 2015 Aug; 134(4):611-7. PubMed ID: 25963375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
